CTRI/2026/07/114063进行中(未招募)不适用
Synergistic Effects of Goal-Directed Mean Arterial Pressure with Sequential Ultrafiltration on Coagulation Dynamics and Postoperative Outcomes in Adult Cardiopulmonary Bypass - MAP - SUF trial
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age eighteen to eighty years.
- •Elective cardiac surgery requiring full cardiopulmonary bypass.
- •EuroSCORE II between two and ten.
- •Ejection fraction between thirty and fifty percent.
- •Serum creatinine two milligrams per deciliter or less.
- •Estimated glomerular filtration rate between thirty and fifty-nine milliliters per minute per one point seven three square meters.
- •Glycated hemoglobin eight percent or less for participants with diabetes mellitus.
- •Hemoglobin between eight and twelve grams per deciliter.
- •Total leukocyte count between four thousand and fifteen thousand per microliter.
- •Partial thromboplastin time between twenty-five and thirty-five seconds.
- •Prothrombin time between eleven and fourteen seconds.
- •International normalized ratio one point five or less.
- •C-reactive protein ten milligrams per liter or less.
- •Blood lactate four millimoles per liter or less.
- •Written informed consent obtained.
排除标准
- •Emergency cardiac surgery.
- •Redo cardiac surgery.
- •Preoperative mechanical ventilation.
- •Chronic kidney disease Stage Four or higher, with estimated glomerular filtration rate less than thirty milliliters per minute per one point seven three square meters.
- •Severe liver dysfunction with Child Pugh Class greater than Class A.
- •Active inflammatory or autoimmune disease.
- •Deep hypothermic circulatory arrest procedures.
- •Ventricular assist device implantation.
- •Heart transplantation.
研究者
相似试验
招募中
不适用
A Comparative Study of the Effects of Selective Myosin Inhibitors Mavacamten and Cibenzoline on Exercise Tolerance in Patients with Obstructive Hypertrophic CardiomyopathyjRCT104126001545
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118
尚未招募
不适用
A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)Renal Insufficiency, ChronicjRCT2031260364200
